ask="45.50"
ask_size="300"
average_daily_volume="370698"
bid="45.02"
bid_size="100"
book_value="14.23"
change="-1.10"
change_from_200_day_moving_average="-5.16"
change_from_50_day_moving_average="-1.63"
change_from_52_week_high="-16.21"
change_From_52_week_low="14.42"
change_in_percent="-2.40%"
close="44.77"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.44"
ebitda="-97.47M"
eps_estimate_current_year="-4.07"
eps_estimate_next_quarter="-1.13"
eps_estimate_next_year="-1.87"
ex_dividend_date="N/A"
float_shares="24516000"
high="47.10"
high_52_weeks="60.98"
last_trade_date="3/1/2017"
last_trade_price="44.77"
last_trade_size="17753"
last_trade_time="4:00pm"
low="44.01"
low_52_weeks="30.35"
market_capitalization="1.23B"
moving_average_200_day="49.93"
moving_average_50_day="46.40"
name="Five Prime Therapeutics
Inc."
notes="N/A"
one_year_target_price="60.50"
open="46.73"
pe_ratio="N/A"
peg_ratio="0.20"
percent_change_from_200_day_moving_average="-10.33%"
percent_change_from_50_day_moving_average="-3.51%"
percent_change_from_52_week_high="-26.58%"
percent_change_from_52_week_low="+47.51%"
previous_close="45.87"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.22"
price_per_sales="41.11"
revenue="30.69M"
shares_outstanding="27509000"
short_ratio="6.80"
stock_exchange="NMS"
symbol="FPRX"
volume="774864"
weeks_range_52="30.35 - 60.98"
